VJHemOnc is committed to improving our service to you

MPN Advances Day 2019 | Immunotherapy for MPNs: where do we stand?

VJHemOnc is committed to improving our service to you

Bethan Psaila

Bethan Psaila, MBBS, MRCP, FRCPath, PhD, University of Oxford, Oxford, UK, gives an overview of where we currently stand with immunotherapy in myeloproliferative neoplasms (MPNs), highlighting an exciting new potential target. This interview took place at the MPN Advances Day 2019 in London, UK.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter